Cross-inhibition of angiotensin AT1 receptors supports the concept of receptor oligomerization

Neurochemistry International

Volumn 51, Issue 5, 2007, Pages 261-267

  Karip, Eszter ^a   Turu, Gábor ^a   Süpeki, Katinka ^a   Szidonya, László ^a   Hunyady, László ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Angiotensin II; G protein; Inositol phosphate response; Receptor dimerization; Receptor oligomerization; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; BETA ADRENERGIC RECEPTOR; CANDESARTAN; CELL SURFACE RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL PHOSPHATE; OLIGOMER;

ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CONTROLLED STUDY; DIMERIZATION; ENDOCRINE SYSTEM; GENE MUTATION; INHIBITION KINETICS; INTERNALIZATION; LIGAND BINDING; NONHUMAN; OLIGOMERIZATION; ONTOGENY; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; CERCOPITHECUS AETHIOPS; COS CELLS; DNA, COMPLEMENTARY; INOSITOL PHOSPHATES; MUSCLE, SMOOTH, VASCULAR; MUTAGENESIS, SITE-DIRECTED; MUTATION; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; TETRAZOLES; TRANSFECTION;

EID: 34548505278     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.05.018     Document Type: Article

References (48)

1. AbdAlla S., Lother H., Abdel-Tawab A.M., and Quitterer U. The angiotensin II AT2 receptor is an AT1 receptor antagonist. J. Biol. Chem. 276 (2001) 39721-39726
2. AbdAlla S., Lother H., el Massiery A., and Quitterer U. Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat. Med. 7 (2001) 1003-1009
3. AbdAlla S., Lother H., Langer A., el Faramawy Y., and Quitterer U. Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis. Cell 119 (2004) 343-354
4. AbdAlla S., Lother H., and Quitterer U. AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature 407 (2000) 94-98
5. Agnati L.F., Fuxe K., Zoli M., Rondanini C., and Ogren S.O. New vistas on synaptic plasticity-the receptor mosaic hypothesis of the engram. Med. Biol. 60 (1982) 183-190
6. Angers S., Salahpour A., Joly E., Hilairet S., Chelsky D., Dennis M., and Bouvier M. Detection of beta(2)-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 3684-3689
7. Avissar S., Amitai G., and Sokolovsky M. Oligomeric structure of muscarinic receptors is shown by photoaffinity-labeling-subunit assembly may explain high-affinity and low-affinity agonist states. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 156-159
8. Bakker R.A., Dees G., Carrillo J.J., Booth R.G., Lopez-Gimenez J.F., Milligan G., Strange P.G., and Leurs R. Domain swapping in the human histamine H-1 receptor. J. Pharm. Exp. Ther. 311 (2004) 131-138
9. Barki-Harrington L., Luttrell L.M., and Rockman H.A. Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo. Circulation 108 (2003) 1611-1618
10. Bouvier M., Heveker N., Jockers R., Marullo S., and Milligan G. BRET analysis of GPCR oligomerization: newer does not mean better. Nat. Methods 4 (2007) 3-4
11. Breit A., Lagace M., and Bouvier M. Hetero-oligomerization between beta 2-and beta 3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties. J. Biol. Chem. 279 (2004) 28756-28765
12. Carrillo J.J., Pediani J., and Milligan G. Dimers of class A G protein-coupled receptors function via agonist-mediated trans-activation of associated G proteins. J. Biol. Chem. 278 (2003) 42578-42587
13. Cvejic S., and Devi L.A. Dimerization of the delta opioid receptor: implication for a role in receptor internalization. J. Biol. Chem. 272 (1997) 26959-26964
14. Fierens F.L., Vanderheyden P.M., Gáborik Z., Minh T.L., Backer J.P., Hunyady L., Ijzerman A., and Vauquelin G. Lys(199) mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists. J. Renin Angiotensin Aldosterone Syst. 1 (2000) 283-288
15. Fotiadis D., Liang Y., Filipek S., Saperstein D.A., Engel A., and Palczewski K. Atomic-force microscopy: rhodopsin dimers in native disc membranes. Nature 421 (2003) 127-128
16. 1 angiotensin receptor activation and signaling. Endocrinology 144 (2003) 2220-2228
17. Hansen J.L., Theilade J., Haunso S., and Sheikh S.P. Oligomerization of wild type and non-functional mutant angiotensin II type I receptors inhibits G alpha(q) protein signaling but not ERK activation. J. Biol. Chem. 279 (2004) 24108-24115
18. Hebert T.E., Loisel T.P., Adam L., Ethier N., St. Onge S., and Bouvier M. Functional rescue of a constitutively desensitized beta(2)AR through receptor dimerization. Biochem. J. 330 (1998) 287-293
19. Hebert T.E., Moffett S., Morello J.P., Loisel T.P., Bichet D.G., Barret C., and Bouvier M. A peptide derived from a beta(2)-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J. Biol. Chem. 271 (1996) 16384-16392
20. 1 receptor. Trends Pharmacol. Sci. 17 (1996) 135-140
21. 1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol. Endocrinol. 20 (2006) 953-970
22. James J.R., Oliveira M.I., Carmo A.M., Iaboni A., and Davis S.J. A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer. Nat. Methods 3 (2006) 1001-1006
23. Jones K.A., Borowsky B., Tamm J.A., Craig D.A., Durkin M.M., Dai M., Yao W.J., Johnson M., Gunwaldsen C., Huang L.Y., Tang C., Shen Q.R., Salon J.A., Morse K., Laz T., Smith K.E., Nagarathnam D., Noble S.A., Branchek T.A., and Gerald C. GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 396 (1998) 674-679
24. Jordan B.A., Trapaidze N., Gomes I., Nivarthi R., and Devi L.A. Oligomerization of opioid receptors with beta(2)-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 343-348
25. Kaupmann K., Malitschek B., Schuler V., Heid J., Froest W., Beck P., Mosbacher J., Bischoff S., Kulik A., Shigemoto R., Karschin A., and Bettler B. GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature 396 (1998) 683-687
26. Kristiansen K. Molecular mechanisms of ligand binding, signaling and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol. Ther. 103 (2004) 21-80
27. Lavoie C., Mercier J.F., Salahpour A., Umapathy D., Breit A., Villeneuve L.R., Zhu W.Z., Xiao R.P., Lakatta E.G., Bouvier M., and Hebert T.E. Beta(1)/beta(2)-adrenergic receptor heterodimerization regulates beta(2)-adrenergic receptor internalization and ERK signaling efficacy. J. Biol. Chem. 277 (2002) 35402-35410
28. Liang Y., Fotiadis D., Filipek S., Saperstein D.A., Palczewski K., and Engel A. Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J. Biol. Chem. 278 (2003) 21655-21662
29. Lopez-Gimenez J.F., Canals M., Pediani J.D., and Milligan G. The alpha1b-adrenoceptor exists as a higher-order oligomer: effective oligomerization is required for receptor maturation, surface delivery and function. Mol. Pharmacol. 71 (2007) 1015-1029
30. Maggio R., Novi F., Scarselli M., and Corsini G.U. The impact of G-protein-coupled receptor hetero-oligomerization on function and pharmacology. FEBS J. 272 (2005) 2939-2946
31. Maggio R., Vogel Z., and Wess J. Coexpression studies with mutant muscarinic adrenergic-receptors provide evidence for intermolecular cross-talk between g-protein-linked receptors. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 3103-3107
32. Meyer B.H., Segura J.M., Martinez K.L., Hovius R., George N., Johnsson K., and Vogel H. FRET imaging reveals that functional neurokinin-1 receptors are monomeric and reside in membrane microdomains of live cells. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 2138-2143
33. Milligan G. G protein-coupled receptor dimerization: function and ligand pharmacology. Mol. Pharmacol. 66 (2004) 1-7
34. Milligan G., Pediani J.D., Canals M., and Lopez-Gimenez J.F. Oligomeric structure of the alpha(1b)-adrenoceptor: comparisons with rhodopsin. Vision Res. 46 (2006) 4434-4441
35. Minneman K.P. Heterodimerization and surface localization of G protein-coupled receptors. Biochem. Pharmacol. 73 (2007) 1043-1050
36. Monnot C., Bihoreau C., Conchon S., Curnow K.M., Corvol P., and Clauser E. Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling-reconstitution of the binding site by co-expression of two deficient mutants. J. Biol. Chem. 271 (1996) 1507-1513
37. Noon L.A., Franklin J.M., King P.J., Goulding N.J., Hunyady L., and Clark A.J.L. Failed export of the adrenocorticotrophin receptor from the endoplasmic reticulum in non-adrenal cells: evidence in support of a requirement for a specific adrenal accessory factor. J. Endocrinol. (2002) 174
38. Oro C., Qian H., and Thomas W.G. Type 1 angiotensin receptor pharmacology: signaling beyond G proteins. Pharmacol. Ther. 113 (2007) 210-226
39. Park P.S., Filipek S., Wells J.W., and Palczewski K. Oligomerization of G protein-coupled receptors: past, present and future. Biochemistry 43 (2004) 15643-15656
40. Prinster S.C., Hague C., and Hall R.A. Heterodimerization of G protein-coupled receptors: specificity and functional significance. Pharmacol. Rev. 57 (2005) 289-298
41. Sitaraman S.V., Wang L.X., Wong M., Bruewer M., Hobert M., Yun C.H., Merlin D., and Madara J.L. The adenosine 2b receptor is recruited to the plasma membrane and associates with E3KARP and ezrin upon agonist stimulation. J. Biol. Chem. 277 (2002) 33188-33195
42. Smith R.D., Baukal A.J., Zolyomi A., Gaborik Z., Hunyady L., Sun L., Zhang M., Chen H.C., and Catt K.J. Agonist-induced phosphorylation of the endogenous AT1 angiotensin receptor in bovine adrenal glomerulosa cells. Mol. Endocrinol. 12 (1998) 634-644
43. 1A angiotensin receptors reveal the presence of G protein-independent signaling in C9 cells. Biochem. Pharmacol. 73 (2007) 1582-1592
44. Terrillon S., and Bouvier M. Roles of G-protein-coupled receptor dimerization-from ontogeny to signalling regulation. EMBO Rep. 5 (2004) 30-34
45. Tuccinardi T., Calderone V., Rapposelli S., and Martinelli A. Proposal of a new binding orientation for non-peptide AT1 antagonists: homology modeling, docking and three-dimensional quantitative structure-activity relationship analysis. J. Med. Chem. 49 (2006) 4305-4316
46. von Zastrow M., Link R., Daunt D., Barsh G., and Kobilka B. Subtype-specific differences in the intracellular sorting of G protein-coupled receptors. J. Biol. Chem. 268 (1993) 763-766
47. Wei H.J., Ahn S., Shenoy S.K., Karnik S.S., Hunyady L., Luttrell L.M., and Lefkowitz R.J. Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 10782-10787
48. White J.H., Wise A., Main M.J., Green A., Fraser N.J., Disney G.H., Barnes A.A., Emson P., Foord S.M., and Marshall F.H. Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 396 (1998) 679-682